HomeSHTDF • OTCMKTS
add
Sinopharm Group Co Ltd
Nakaraang pagsara
$2.60
Sakop ng taon
$2.11 - $2.60
Market cap
60.63B HKD
Average na Volume
78.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 145.44B | -1.53% |
Gastos sa pagpapatakbo | 6.37B | -6.94% |
Net na kita | 1.85B | 16.88% |
Net profit margin | 1.27 | 18.69% |
Kita sa bawat share | — | — |
EBITDA | 4.66B | 3.57% |
Aktuwal na % ng binabayarang buwis | 24.66% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 38.77B | — |
Kabuuang asset | 418.38B | — |
Kabuuang sagutin | 286.21B | — |
Kabuuang equity | 132.17B | — |
Natitirang share | 3.12B | — |
Presyo para makapag-book | 0.10 | — |
Return on assets | 2.46% | — |
Return on capital | 4.71% | — |
Cash Flow
Net change in cash
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.85B | 16.88% |
Cash mula sa mga operasyon | -4.97B | 26.15% |
Cash mula sa pag-invest | 781.72M | -19.99% |
Cash mula sa financing | -4.04B | -162.10% |
Net change in cash | -8.22B | -12.59% |
Malayang cash flow | -1.34B | — |
Tungkol
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Itinatag
2003
Website
Mga Empleyado
100,251
